Literature DB >> 8631348

A molecular map of the interactions between titin and myosin-binding protein C. Implications for sarcomeric assembly in familial hypertrophic cardiomyopathy.

A Freiburg1, M Gautel.   

Abstract

The thick filaments of vertebrate striated muscles contain with myosin a number of accessory proteins of the intracellular immunoglobulin superfamily, which are localized in a distinct pattern of stripes 43 nm apart. The specific localization of these proteins is believed to be due partly to their interaction with the giant muscle protein titin (also called connectin), which spans the entire sarcomere and may act as a molecular ruler. We have used recombinant fragments of titin covering the thick filament region to investigate their interaction with myosin-binding protein C (MyBP-C) from skeletal and cardiac muscle. The interaction of titin and MYBP-C is directed by a subset of titin immunoglobulin domains that are specific for the C-region of the thick filament, supporting the ruler hypothesis for the myosin-binding proteins. The interaction of recombinant titin with overlapping fragments of human cardiac MyBP-C maps the titin-binding site within the C-terminal region, which is deleted in patients suffering from the chromosome-11-associated form of familial hypertrophic cardiomyopathy. This disorder is therefore likely to be the result of thick-filament misassembly by abolishing the ternary interaction of titin, myosin and MyBP-C.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631348     DOI: 10.1111/j.1432-1033.1996.00317.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  112 in total

Review 1.  The molecular genetic basis for hypertrophic cardiomyopathy.

Authors:  A J Marian; R Roberts
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

2.  Structural insight into unique cardiac myosin-binding protein-C motif: a partially folded domain.

Authors:  Jack W Howarth; Srinivas Ramisetti; Kristof Nolan; Sakthivel Sadayappan; Paul R Rosevear
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

Review 3.  Structure, interactions and function of the N-terminus of cardiac myosin binding protein C (MyBP-C): who does what, with what, and to whom?

Authors:  Mark Pfuhl; Mathias Gautel
Journal:  J Muscle Res Cell Motil       Date:  2012-04-20       Impact factor: 2.698

4.  Cardiac myosin binding protein C and its phosphorylation regulate multiple steps in the cross-bridge cycle of muscle contraction.

Authors:  Arthur T Coulton; Julian E Stelzer
Journal:  Biochemistry       Date:  2012-04-06       Impact factor: 3.162

Review 5.  Hypertrophic cardiomyopathy.

Authors:  Carolyn Y Ho
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

6.  Myosin binding protein C interaction with actin: characterization and mapping of the binding site.

Authors:  Inna N Rybakova; Marion L Greaser; Richard L Moss
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

Review 7.  The ubiquitin-proteasome system and cardiovascular disease.

Authors:  Saul R Powell; Joerg Herrmann; Amir Lerman; Cam Patterson; Xuejun Wang
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

8.  The structure of isolated cardiac Myosin thick filaments from cardiac Myosin binding protein-C knockout mice.

Authors:  Robert W Kensler; Samantha P Harris
Journal:  Biophys J       Date:  2007-11-09       Impact factor: 4.033

9.  Cardiac myosin binding protein C phosphorylation is cardioprotective.

Authors:  Sakthivel Sadayappan; Hanna Osinska; Raisa Klevitsky; John N Lorenz; Michelle Sargent; Jeffrey D Molkentin; Christine E Seidman; Jonathan G Seidman; Jeffrey Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

10.  The mechanical stability of immunoglobulin and fibronectin III domains in the muscle protein titin measured by atomic force microscopy.

Authors:  M Rief; M Gautel; A Schemmel; H E Gaub
Journal:  Biophys J       Date:  1998-12       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.